Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake].

Presse medicale (Paris, France : 1983) - 1 May 2012

Bou Khalil Rami

Abstract excerpt

BACKGROUND: The association between schizophrenia and the metabolic syndrome is frequent and well studied in the literature. The risk of induction of this syndrome by atypical antipsychotic drugs in patients with schizophrenia is well known. The aim of this study is to evaluate the association between schizophrenia and the metabolic syndrome independently from the risk of induction of this syndrome by atypical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Gene-Environment Interaction
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin Resistance

Share to Metabolic Syndrome

Share to Obesity, Abdominal

Share to Schizophrenia

Source

Identifiers

PMID: 22154487
DOI: 10.1016/j.lpm.2011.10.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake].PMID 22154487Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity Read ↗

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?Semantic proximity Read ↗

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.Semantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismSemantic proximity Read ↗

Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatmentSemantic proximity Read ↗

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.Semantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic DrugsSemantic proximity Read ↗

The Multidimensional Nature of Metabolic Syndrome in Schizophrenia: Lessons from Studies of One-Carbon Metabolism and DNA MethylationSemantic proximity Read ↗

Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptomsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.